Publié sur dans “Monde”, langue – English. 3 pages.
“Angioedema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Angioedema Report is to understand the market and pipeline status of the drugs around the Angioedema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Delv Plus
